SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-021446
Filing Date
2018-01-26
Accepted
2018-01-26 15:19:03
Documents
6
Period of Report
2018-01-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d527496d8k.htm 8-K 18828
2 EX-1.1 d527496dex11.htm EX-1.1 194447
3 EX-5.1 d527496dex51.htm EX-5.1 6024
4 GRAPHIC g527496g35l02.jpg GRAPHIC 3687
5 GRAPHIC g527496g39r12.jpg GRAPHIC 6783
6 GRAPHIC g527496g40x42.jpg GRAPHIC 2801
  Complete submission text file 0001193125-18-021446.txt   239101
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36276 | Film No.: 18551586
SIC: 2834 Pharmaceutical Preparations